SCHEMBL25258462

SCHEMBL25258462

CN1CCN(Cc2ccc(O)c(C3OCCO3)n2)CC1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALOX15 P16050 1/20 0.45
▸ ERAP1 Q9NZ08 3/20 0.40
▸ KDM4E B2RXH2 5/20 0.39
▸ ALDH1A1 P00352 3/20 0.39
▸ MAPT P10636 3/20 0.39
▸ RXFP1 Q9HBX9 2/20 0.38
▸ HPGD P15428 1/20 0.38
▸ HSD17B10 Q99714 1/20 0.38
▸ MEN1 O00255 1/20 0.38
▸ GLA P06280 1/20 0.38
▸ GAA P10253 1/20 0.38
▸ KMT2A Q03164 1/20 0.38
▸ GRIN2B Q13224 1/20 0.37
▸ LMNA P02545 2/20 0.37
▸ TP53 P04637 1/20 0.37
▸ CXCR4 P61073 1/20 0.37
▸ ATM Q13315 1/20 0.36
▸ MC4R P32245 1/20 0.36
▸ PIK3R1 P27986 1/20 0.35
▸ PIK3CA P42336 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25224266 0.88 SIGMAR1 (0.36) ALOX15ERAP1KDM4EALDH1A1MAPT
SCHEMBL25268364 0.86 ALOX15 (0.56) ALOX15KDM4EALDH1A1MAPTHPGD
SCHEMBL25267888 0.86 KDM4E (0.51) ALOX15KDM4EALDH1A1MAPTHPGD
SCHEMBL25267386 0.86 NOS3 (0.41) ALOX15ERAP1KDM4EALDH1A1MAPT
SCHEMBL25222075 0.83 DRD4 (0.48) ALOX15KDM4EALDH1A1MAPTHPGD
SCHEMBL25254185 0.82 KDM4E (0.47) ALOX15KDM4EALDH1A1MEN1GAA
SCHEMBL30503238 0.79 KDM4E (0.46) KDM4EALDH1A1MAPTRXFP1HPGD
SCHEMBL25221819 0.79 KDM4E (0.46) KDM4EALDH1A1MAPTRXFP1HPGD
SCHEMBL25222638 0.78 TLR9 (0.42) ALOX15KDM4EALDH1A1MAPTHPGD
SCHEMBL25256514 0.76 ALOX15 (0.42) ALOX15KDM4EALDH1A1MAPTHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230270750-A1 CARBALDEHYDE OXIMES AS BUTYRYLCHOLINESTERASE REACTIVATORS CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 2023-08-31 — — US disclosed
US-20230270750-A1 CARBALDEHYDE OXIMES AS BUTYRYLCHOLINESTERASE REACTIVATORS CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 2023-08-31 — — US disclosed
US-20230270750-A1 CARBALDEHYDE OXIMES AS BUTYRYLCHOLINESTERASE REACTIVATORS CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 2023-08-31 — — US disclosed
CN-116472267-A Butyrylcholinesterase reactivating agent 法兰西国由中央军队卫生服务局代表 2023-07-21 — — CN disclosed
EP-4188919-A1 CARBALDEHYDE OXIMES AS BUTYRYLCHOLINESTERASE REACTIVATORS Etat Français représenté par la Direction Centrale Du Service de Santé des Armées (FR) 2023-06-07 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230270750-A1 CARBALDEHYDE OXIMES AS BUTYRYLCHOLINESTERASE REACTIVATORS BCHE, ACHE, CHAT ALOX15 824/4885ERAP1 2015/4885KDM4E 1130/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback